Australia has already spent hundreds of millions over the past 36 months after raising the prices of 950 PBS medicines in 2022 to secure supply in a challenging global environment. If global pressure now forces higher prices for other medicines, so be it, but of course, it would be just another stop-gap solution for a system built on a terrible patient-loathing law. …
Australia can increase prices in response to pressure, as it did just 36 months ago for 950 medicines
December 2, 2025 Latest NewsBioPharmaComment
Latest Video
Georgia Forrest
New Stories
-
US pricing push gets real with Australia included in comparison list
December 22, 2025 - - Latest News -
Parsimony has unfortunately become an enduring test of the institution's legitimacy
December 20, 2025 - - Latest News -
PBAC delivers a broad range of outcomes in November, including for obesity
December 20, 2025 - - Latest News -
Takeda’s next-generation psoriasis therapy delivers landmark Phase 3 results
December 19, 2025 - - Latest News -
A 'fit for purpose' HTA system will be accompanied by a 'fit for purpose' cost recovery framework
December 19, 2025 - - Latest News -
Cleo Diagnostics raises funds to accelerate US launch and advance ovarian cancer screening
December 18, 2025 - - Australian Biotech -
Actinogen crosses key milestone as pivotal Alzheimer’s trial fully enrols
December 18, 2025 - - Australian Biotech